Patient-centered care is becoming more important in healthcare and life sciences. A 2016 report by Accenture Life Sciences shows that about 85% of large drug companies plan to spend more on patient-centered services in the next two years. These services include programs to help patients follow treatments, remote patient monitoring, and medication delivery and support.
Among these companies, 67% said their main goal is to improve patient health outcomes. Also, 91% expect to offer six or more patient services soon, up from 73% currently. This shows a plan to support patients better at different stages of their care.
Patients value medication delivery and support (85%), remote monitoring (79%), and adherence program management (77%) the most. These services help improve health results and make it easier for patients to follow their treatment plans and stay involved.
However, there are challenges. About 73% of companies say there is no single person responsible for patient services. This can slow down progress and reduce how well services work. Also, only 19% of patients know about these services. Measuring how services affect health is hard too, with 40% of leaders saying this is a problem.
For medical managers and IT leaders, it is important to add patient-focused technologies and simplify workflows to improve patient involvement and show clear benefits.
Artificial intelligence (AI) helps improve how patients follow treatments and the quality of healthcare. AI systems collect data from medical records, monitoring devices, and patient reports. This data helps doctors find patients at risk, predict problems with treatment adherence, and plan better interventions.
For example, ConcertAI uses AI to support cancer care. Their PrecisionSuite platform combines real-world data and AI to help make better clinical trial decisions and improve personalized medicine. By studying millions of patient records and biomarkers, ConcertAI helps doctors understand how treatments work for each patient.
ConcertAI’s CancerLinQ® platform offers real-time clinical insights to improve cancer care. It tracks quality measures and helps doctors select trials faster. This helps doctors change treatments as needed and improves patient results and research efficiency.
IBM’s watsonx™ platform uses conversational AI to automate customer service. This helped companies like Humana reduce pre-service calls, which lowers staff workload and improves patient communication. Such AI tools give quick and correct answers to patient questions, helping patients stay engaged and satisfied.
Healthcare leaders can use AI tools to reduce manual work, make workflows smoother, and improve communication between patients and providers.
Conversational AI automates calls, appointment reminders, prescription requests, and patient questions. This reduces the work of front-office staff and avoids delays caused by doing these tasks manually. Simbo AI, for example, provides phone automation made for healthcare. Their AI answers many calls efficiently and offers quick, proper responses. Automating these calls makes patients happier by cutting wait times and giving fast access to information.
Platforms like ConcertAI’s AI medical tools (such as TeraRecon) help doctors by analyzing medical images and data. This lowers the mental workload on doctors and helps them make accurate and faster diagnoses. AI also combines different patient records and biomarker info so doctors can make clearer decisions and give better, personalized care.
AI-powered remote monitoring helps patients follow treatments better. It collects health data through wearable devices or mobile apps. Healthcare teams can track chronic diseases, spot early warning signs, and step in when needed. Predictive analytics forecast health risks and chances patients might stop treatment, allowing early care adjustments. Drug companies are investing more in remote monitoring to improve patient results.
Life sciences companies and clinics running clinical trials can use AI to handle study schedules, patient recruitment, and paperwork. ConcertAI’s PrecisionTRIALS helps speed up trial decisions and lower risks. This makes research more productive and saves resources.
Also, IBM’s watsonx offers cloud systems for safe data management, rule-following, and AI analytics. This support is important for handling complex healthcare tasks.
AI also changes business strategies in life sciences. Using patient data and AI analysis, drug companies can improve marketing, support patient treatment adherence, and customize communication.
ConcertAI’s AI-powered PrecisionGTM™ tool helps companies understand cancer treatment markets. By studying real-world data, drug companies learn more about treatment options, competition, and patient groups. This helps them invest smartly in patient services that boost medication use and loyalty.
About 95% of drug companies plan to invest more in digital channels, showing the need to communicate well. Social media, online portals, and AI chatbots help reach patients and teach them better.
Also, 81% of companies depend on healthcare providers to inform patients about services. But since only 19% of patients know about these services, using AI tools to improve communication between providers and patients is very important.
Modern healthcare knows it is important to understand patients beyond just their symptoms. Digital healthcare and social media have made patients active in decisions about their care.
IQVIA’s Social Media Intelligence (SMI) team uses AI to study social media comments alongside traditional doctor-led research. This method captures patient feelings, behaviors, and needs on a larger scale than usual surveys.
For example, research on people with Type 2 Diabetes using insulin pumps found patient fears and barriers from social media posts. These insights were used to improve patient support, doctor-patient communication, and business plans.
Medical managers can use these insights to change how they communicate, improve education, and address patient worries before treatment drops occur. This helps care delivery and life sciences companies’ market strategies.
Medical managers in U.S healthcare can help bring AI tools that focus on patients to improve how well patients follow treatments, the quality of care, and business success. Pharmaceutical companies are focusing more on patient services and using AI tools. This creates chances to:
By solving technical, operational, and educational problems, healthcare groups can improve patient health, cut costs, and work more efficiently in the changing U.S. healthcare system. AI’s growing use in patient-centered care offers a way to provide more responsive, efficient, and evidence-based health services.
This overview shows how AI and patient-focused strategies with real-world data are changing adherence programs, clinical care, and business in U.S. life sciences and healthcare. Medical practices that take on these ideas while handling challenges can improve care and use resources better in a competitive market.
ConcertAI provides generative and agentic AI solutions tailored for life sciences and healthcare, accelerating translational medicine, clinical trials, imaging, diagnostics, and oncology care by integrating real-world patient data and AI technologies.
ConcertAI integrates deep, broad, multi-modal real-world data, including oncology-specific biomarkers and clinical records, to drive therapeutic insights, support smarter clinical trial decisions, and enhance patient outcomes through AI-driven analysis and solutions.
The Precision Suite includes PrecisionExplorer™ (generative AI for RWD analysis), PrecisionTRIALS™ (facilitates smarter and faster clinical trial decisions), PrecisionGTM™ (AI-powered oncology strategy insights), and Precision360™ (accelerates oncology research with data integration).
AI enhances clinical trial success by improving patient recruitment, optimizing study timelines, providing real-time clinical insights, and enabling smarter decision-making to de-risk trials and accelerate translational and clinical development processes.
ConcertAI offers digital trial solutions, commercial solutions focusing on patient adherence and outcomes, AI-powered medical imaging interpretation tools, and real-world evidence platforms, all designed to improve healthcare delivery and research across life sciences.
ConcertAI collaborates with industry leaders like NVIDIA, Caris Life Sciences, NeoGenomics, AbbVie, Janssen Pharmaceuticals, and regulatory bodies like the FDA to enhance oncology research, digital clinical trials, and real-world evidence applications.
CancerLinQ® aggregates real-time clinical insights, supports quality measure tracking, improves cancer care delivery, and offers trial screening support by leveraging curated real-world data to advance oncology patient outcomes and research efficiency.
Through platforms like TeraRecon, ConcertAI provides AI-driven medical image interpretation, reducing cognitive burden on healthcare providers, improving diagnostic accuracy, and enhancing clinical decision-making in oncology and other medical fields.
By integrating extensive oncology datasets covering millions of unique patients, multiple US states, cancer center locations, and numerous clinically relevant biomarkers, ConcertAI ensures comprehensive, high-quality data for AI analysis and research.
ConcertAI delivers patient-centered data aggregation and AI-driven assistants that optimize patient adherence and outcomes, while also providing commercial solutions that enhance brand success through data-informed marketing and healthcare delivery strategies.